NEW YORK (GenomeWeb) – Thermo Fisher Scientific brand One Lambda said today that it has signed an exclusive licensing agreement with Transcriptome Sciences for its transplant rejection testing technology, the Molecular Microscope Diagnostic System (MMDx).

MMDx is a central diagnostic system that uses Thermo Fisher's MyGeneChip custom microarrays to measure transcript levels in biopsy samples, and then apply algorithms that compare those expression results to a set of reference biopsies for diagnosing organ transplant rejection. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.